Navigation Links
Rigel Announces Third Quarter 2008 Financial Results and Clinical Update
Date:11/3/2008

o Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to relating to the potential efficacy of R788, as well as Rigel's plans to pursue clinical development of R788 and other product candidates, and the timing thereof, the market opportunity for its product candidates, expansion of and changes in its product portfolio and its plans to pursue collaboration partnerships for product candidates. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "plans," "potential," "intends," "indicates," "promising," "expects," "anticipates" and similar expressions are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including risks associated with the timing and success of clinical trials and the commercialization of product candidates, potential problems that may arise in the clinical testing and approval process and R
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Rigel to Host Update Conference Call
2. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
3. Rigel to Present at BIO CEO & Investor Conference
4. Rigel Announces Pricing of Public Offering of Common Stock
5. Rigel to Present Research Programs at Scientific Conferences
6. Rigel to Present at BIO Investor Forum 2007
7. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
8. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
9. OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector
10. Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer
11. BMP Sunstone Announces Participation in November Investor Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Drug Discov...s & Opportunities ,, http://www.reportlin...lobal-Update-of-Market-Trends--Opportunities.html ...ngoing element of every pharmaceutical company,s b...
(Date:12/2/2009)..., COPENHAGEN, Dec. 2 The world,s f...oprene technology, a breakthrough alternative to r...e manufacture of synthetic rubber with renewable b...his week. One tire will be on display at a lounge ...ernational Airport throughout December 21, while t...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - O...ny") (TSX:ONC; NASDAQ: ONCY ) announced today that...offering, the underwriters have exercised in full ...ional 637,500 units. Each unit is comprised of one...arrant, and was sold at a price of US$3.00 per uni...
(Date:12/2/2009)..., LELYSTAD, The Netherlands, December 2 /PRNew...d biotechnology company focusing on protein mimick...eutics today announced that it,has appointed Wim E..., Dr. Mol will be responsible for all of Pep...nt and strategic direction of the company. He brin...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2
...ass., Feb. 3 Abt Associates announced that Ricky ...Associate. After a brief orientation to the firm,... education work in September 2009. Dr. Takai brin... and management of federal evaluation studies in t...cently, Dr. Takai served as Associate Commissioner...
...b. 3 AngioGenex Inc. (OTC Bulletin Board: AGGX.OB...s pioneering the targeting of Id genes and protein...enic drugs to treat cancer. Today the Company anno...t scientific meetings that demonstrate the ability...o mitigate tumor formation and metastases. , , Dr...
.... 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nas...pecializing in the development of innovative thera... announced that Robert Kirkman, M.D., President an...h Annual BIO CEO & Investor Conference in New ...bruary 9, 2009. , A live and archived webcast of D...
Other Biology Technology:Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates 2AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences 2AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences 3
(Date:12/3/2009)... Coral reef fish can undergo a personality change...tudy suggesting that climate change may make some ...species of young damselfish on Australia,s Great B...e reef fish are either consistently timid, or cons...es are even more marked as water temperatures rise...
(Date:12/3/2009)... Forest dwellers must be included in the design o...to avoid a humanitarian crisis, according to a sci...day in Nature , Dr Simon Lewis argues that at lea...at Copenhagen, known as REDD (Reducing Emissions f... to forest dwellers directly, and their property r...
(Date:12/3/2009)... The UK leads the world when it comes to investme...Engineering and Physical Sciences Research Council...more is needed: "Scientific and engineering resear... and solar power solutions, but more investment is...olutions if we are to meet our carbon emission tar...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Research is vital to a cleaner, greener, low carbon future 2Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology 50348 1Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology 50348 2Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology 50348 3AUDIO from Medialink and AARP 3A Helping Older Americans Buy Groceries in a Snap 50343 1BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 1BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 2BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 3BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 4
...y of Florida-led study has determined that Titanis...rror bird," arrived in North America from South Am...continents. , UF paleontologist Bruce MacFadden sa...que that analyzes rare earth elements in a new app... in Texas and Florida, the only places in North Am...
...d researchers tapping the massive flow of DNA sequ...their recent developments at the 2nd Annual U.S. D...I) User Meeting. DOE JGI is the world,s only user ...equencing available to a diverse research communit... not have access to such a resource to advance the...
...ogy, the size of a mobile phone, which could save ... scientists from The University of Nottingham. The...ential danger. It is small and easy to use so that...baby’s heart beat without having to go into hospit...gy allows them to do this. , It took 15 years of p...
Other Biology News:'Terror bird' arrived in North America before land bridge, study finds 2A revolution in the monitoring of unborn babies 2A revolution in the monitoring of unborn babies 3
Mouse Serum from Innovative Research
Varian 4000 Ion Trap GC/MS from Varian, Inc.
GeneRacer Kit with AMV RT and TOPO TA Cloning kit for Sequencing from Invitrogen
...esenilin 2 Alzheimer's disease (AD) patients with...in the presenilin proteins (PSEN1; PSEN2) or the a...ed mutations result in increased production of the...yloid deposits found in AD brains). Presenilins ar...
Biology Products: